Lisa Walter
Stock Analyst at RBC Capital
(2.31)
# 2,631
Out of 5,162 analysts
110
Total ratings
52.7%
Success rate
1.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lisa Walter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRYS Krystal Biotech | Maintained: Buy | $375 | $315.34 | +18.92% | 5 | Nov 19, 2026 | |
| FDMT 4D Molecular Therapeutics | Reiterated: Buy | $35 | $10.46 | +234.61% | 26 | Nov 16, 2026 | |
| EYPT EyePoint | Reiterated: Hold | $1 | $0.272 | +267.65% | 12 | Nov 12, 2026 | |
| MGTX MeiraGTx Holdings | Reiterated: Buy | $27 | $8.32 | +224.52% | 10 | Nov 12, 2026 | |
| IRD Opus Genetics | Reiterated: Buy | $9 → $11 | $3.92 | +180.61% | 3 | Nov 10, 2026 | |
| OCUL Ocular Therapeutix | Reiterated: Buy | $30 | $5.94 | +405.05% | 12 | Nov 9, 2026 | |
| VRDN Viridian Therapeutics | Reiterated: Buy | $38 → $41 | $30.12 | +36.12% | 10 | Nov 5, 2026 | |
| UTHR United Therapeutics | Reiterated: Buy | $697 → $725 | $577.34 | +25.58% | 17 | Nov 4, 2026 | |
| MIRM Mirum Pharmaceuticals | Reiterated: Buy | $155 | $92.49 | +67.59% | 5 | Nov 3, 2026 | |
| RYTM Rhythm Pharmaceuticals | Reiterated: Buy | $159 | $119.04 | +33.57% | 10 | Nov 3, 2026 |
Krystal Biotech
Nov 19, 2026
Maintained: Buy
Price Target: $375
Current: $315.34
Upside: +18.92%
4D Molecular Therapeutics
Nov 16, 2026
Reiterated: Buy
Price Target: $35
Current: $10.46
Upside: +234.61%
EyePoint
Nov 12, 2026
Reiterated: Hold
Price Target: $1
Current: $0.272
Upside: +267.65%
MeiraGTx Holdings
Nov 12, 2026
Reiterated: Buy
Price Target: $27
Current: $8.32
Upside: +224.52%
Opus Genetics
Nov 10, 2026
Reiterated: Buy
Price Target: $9 → $11
Current: $3.92
Upside: +180.61%
Ocular Therapeutix
Nov 9, 2026
Reiterated: Buy
Price Target: $30
Current: $5.94
Upside: +405.05%
Viridian Therapeutics
Nov 5, 2026
Reiterated: Buy
Price Target: $38 → $41
Current: $30.12
Upside: +36.12%
United Therapeutics
Nov 4, 2026
Reiterated: Buy
Price Target: $697 → $725
Current: $577.34
Upside: +25.58%
Mirum Pharmaceuticals
Nov 3, 2026
Reiterated: Buy
Price Target: $155
Current: $92.49
Upside: +67.59%
Rhythm Pharmaceuticals
Nov 3, 2026
Reiterated: Buy
Price Target: $159
Current: $119.04
Upside: +33.57%